Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Burns & Levinson LLP
Burns & Levinson Guides Indevus Through Significant Pharmaceutical Transaction
March 28th, 2009
Burns & Levinson LLP, a leading Boston law firm, announced that Endo Pharmaceuticals Holdings Inc. completed its initial tender offer to acquire Indevus Pharmaceuticals, Inc. of Lexington, Mass., a long-term client of Burns & Levinson. This unique and complex transaction includes initial cash payments of approximately $370 million, or $4.50 per share of Indevus stock, and up to an additional approximately $267 million, or $3.00 per share, in cash payable in the future upon achievement of certain regulatory and sales milestones. The transaction signals a departure from most deals that typically call for strict financing amid the economic downturn. Under the terms of the...
Source: Law & Health Weekly (2009-03-28)
|
